D. E. Shaw & Co., Inc. Lensar, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.5 - $8.88 $249,795 - $295,757	-33,306 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.87 - $8.66 $45,266 - $57,060	-6,589 Reduced 16.52%	33,306 $288,000
Q1 2021 May 17, 2021	SELL	$6.28 - $9.56 $132,426 - $201,591	-21,087 Reduced 34.58%	39,895 $290,000
Q4 2020 Feb 16, 2021	BUY	$6.7 - $12.2 $408,579 - $743,980	60,982 New	60,982 $442,000

4.91M

700

31.3K

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $96.4M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.